Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001219036-14-000012
Filing Date
2014-11-06
Accepted
2014-11-06 11:47:23
Documents
1
Period of Report
2014-11-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 8624
  Complete submission text file 0001219036-14-000012.txt   9910
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
LANCHBURY JERRY S (Reporting) CIK: 0001219036 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 141199540